Search results for: 'pacf infectious'

23 Jun 2016  |  North America  |  Market Research

Growth Opportunities in the US Point-of-care Testing Market

Digital Health Meets Point of Care—Emergence of Mobile Molecular Diagnostics

Infographics

×

The US point-of-care testing (POCT) study provides an extensive analysis for 13 segments: hematology, urinalysis, infectious disease, cardiac, HbA1c, glucose, fecal occult blood test/fecal immunochemical test (FOBT/FIT), coagulation PT/INR, coagulation APTT/ACT, cholesterol, pregnancy, drugs of abuse, and blood gas and electrolytes. Key trends and ...

This deliverable provides research and analysis of the global infectious disease diagnostics market. It includes an in-depth analysis of revenue forecast by segment, drivers and restraints, and technology trends, along with the competitive factors and strategies, and key companies to watch. The global market is primarily driven by the high prevalen...

02 Sep 2025  |  Global  |  Technology Research

Technological Advances in Engineered Cell Therapies, Global, 2025–2029

Emerging Trends and Technologies in Engineered Cell Therapies

Infographics

×

Engineered cell therapies have become a revolutionary medical field, surpassing conventional methods such as systemic medications and prominent immunosuppression to provide long-lasting, programmable, and targeted treatments for complicated diseases. Recent technical developments in engineered cell therapies examine how the rapid growth of cell eng...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations reshaping diagnostics, therapeutics, and clinical workflows across infectious diseases, women’s health, metabolic disorders, neurodegeneration, oncology, rare diseases, and musculoskeletal care. It hi...

The main objective of this research is to estimate test volumes and unit prices for a wide variety of LDTs (genetic) and a few high volume FDA tests for selective therapeutic areas. The tests are categorized by their intended uses across the diagnostic spectrum (risk assessment, screening, diagnosis, staging and prognosis, therapy selection, therap...

30 Apr 2020  |  Global  |  Megatrends

Global Future Risks—Future-proofing your Strategies, 2030

An Assessment of the Top 21 Risks that Threaten the Next Decade

Infographics

×

Our world is evolving rapidly, and so are risks. Rapid innovation, growing political tensions, climate change and the unexpected rise of infectious diseases have made it increasingly complex to anticipate, assess, or mitigate risks. Risks are now increasingly interconnected, which if amplified can trigger a ripple effect across industries, regions...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations reshaping therapeutics, diagnostics, and drug delivery across infectious diseases, oncology, rare genetic disorders, autoimmune conditions, cardiovascular disease, pulmonary fibrosis, neurodegeneratio...

Today, the healthcare industry is focused toward patient centric care and preventative healthcare. Preventative healthcare involves regular screening and diagnosis for diseases before the condition becomes fatal. Early diagnosis improves the clinical outcome of the patients, reduces emergency visits, and subsequently healthcare costs. Usually, ear...

The climate emergency and the intrinsic link between resources and energy in the circular economy escalated in 2022 because of geopolitical chaos. Russia’s invasion of Ukraine fueled a rapid increase in energy prices and supply chain disruptions, which has led to collaboration across key industry verticals to develop innovative technologies and ser...